Congrats to patient IPA longs...It's been a long, arduous 6 months post Nasdaq listing period.
The volume on the US side is incredible. more than double the entire o/s share volume in just two hours of trading. More coming.
Rumours of a deal with a Major will propel this further.
When (not if) that comes, watch out.
They have many more poly-trope concoctions in the works. This pandemic will evolve into an endemic, that will establish the need for new innovative antibody therapies/vaccines/boosters to battle against constantly emerging variants. Think beyond the ability to better deal with Delta (which in itself is great news).
Anyway...I love this company for it's potential to do good and make money for it's shareholders.
MM